(2)
DGAP-News: Vivoryon Therapeutics N.V.
/ Key word(s): AGM/EGM
Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Announces Nominations to Reappoint Ulrich Dauer as CEO and to Appoint Florian Schmid as CFO
29.01.2021 / 18:09
Vivoryon Therapeutics N.V. Announces Nominations
to Reappoint Ulrich Dauer as CEO and to Appoint Florian Schmid as CFO
HALLE (SAALE) / MUNICH, GERMANY, 29 January 2021 - the Board of Directors (
Board) of Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (
Vivoryon) announced today that it will hold an Extraordinary General Meeting of Shareholders (
EGM) on Friday, March 12, 2021. The EGM will take place virtually.
The EGM agenda, explanatory notes and terms of participation have been made public and are available as of January 29, 2021 on the Vivoryon website https://www.vivoryon.com/extraordinary-general-meeting-2021/. Vivoryon shareholders are invited to consult the company website in order to obtain current information on the procedures for participating in the EGM.